Sign Up
OverviewAPI
The ATP assays market is expected to grow from $1.97 billion in 2024 to $3.01 billion by 2028, driven by the rise in personalized medicine and high-throughput screening methods. North America currently leads the market, with Asia-Pacific displaying rapid growth. Luminometric ATP assays are notable for research and clinical diagnostics. Key players are investing in advanced technologies like sanitation monitoring and robotic automation.

Ask a question